Vincenzo Stanghellini

Vincenzo Stanghellini's AcademicInfluence.com Rankings

Physics

#5824

World Rank

#7701

Historical Rank

physics Degrees

Download Badge

Physics

Vincenzo Stanghellini's Degrees

PhD Physics University of Bologna
Masters Physics University of Bologna
Bachelors Physics University of Bologna

Why Is Vincenzo Stanghellini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vincenzo Stanghellini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Functional gastroduodenal disorders (1999) (2488)
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. (2004) (1326)
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. (2007) (674)
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. (1996) (638)
Assessment of gastric emptying using a low fat meal: establishment of international control values (2000) (582)
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators (2008) (471)
Rome IV - Gastroduodenal Disorders. (2016) (404)
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. (2005) (364)
Manometric evaluation of functional upper gut symptoms. (1985) (345)
Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms (2009) (332)
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. (2009) (326)
Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index (2003) (325)
Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms (2004) (312)
Interactions Between Commensal Bacteria and Gut Sensorimotor Function in Health and Disease (2005) (290)
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders (2004) (283)
Diagnosis and treatment of chronic constipation – a European perspective (2011) (273)
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. (1987) (263)
A role for inflammation in irritable bowel syndrome? (2002) (263)
Inflammatory neuropathies of the enteric nervous system. (2004) (259)
Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders (2012) (246)
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction (2004) (228)
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. (1992) (223)
Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). (1999) (220)
New pathophysiological mechanisms in irritable bowel syndrome (2004) (219)
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. (1993) (215)
Enteric neuroplasticity evoked by inflammation (2006) (201)
Chronic intestinal pseudo-obstruction. (2007) (192)
The Immune System in Irritable Bowel Syndrome (2011) (185)
Functional gastrointestinal disorders and mast cells: implications for therapy (2006) (181)
Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. (1987) (178)
Stress-induced gastroduodenal motor disturbances in humans: possible humoral mechanisms. (1983) (172)
Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. (2005) (170)
Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome (2011) (164)
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. (1992) (157)
Chronic intestinal pseudo‐obstruction: manifestations, natural history and management (2007) (149)
Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). (1999) (144)
Chronic constipation in the elderly: a primer for the gastroenterologist (2015) (138)
Chronic intestinal pseudo-obstruction. (2008) (136)
The changing clinical profile of celiac disease: a 15-year experience (1998-2012) in an Italian referral center (2014) (132)
Randomized Clinical Trial: Macrogol/PEG 3350 Plus Electrolytes for Treatment of Patients With Constipation Associated With Irritable Bowel Syndrome (2013) (132)
Gastroparesis (2018) (130)
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study (2009) (126)
Reversal of fundic atrophy after eradication of helicobacter pylori (1998) (121)
Gastroparesis: separate entity or just a part of dyspepsia? (2014) (118)
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. (2011) (117)
Review article: molecular, pathological and therapeutic features of human enteric neuropathies (2008) (117)
Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. (2003) (116)
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. (2015) (113)
Gastric emptying of solids in morbid obesity. (1996) (112)
Mechanisms Underlying Visceral Hypersensitivity in Irritable Bowel Syndrome (2011) (109)
Predominant symptoms identify different subgroups in functional dyspepsia (1999) (109)
Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome (2016) (107)
Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts (2013) (106)
Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome. (2015) (104)
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: The PAGI-QOL© (2004) (103)
Current management strategies and emerging treatments for functional dyspepsia (2013) (101)
Systematic Review: Do We Need a New Gastro-Oesophageal Reflux Disease Questionnaire? (2007) (100)
Gastroparesis: a turning point in understanding and treatment (2019) (100)
Chronic intestinal pseudo‐obstruction in children and adults: diagnosis and therapeutic options (2017) (99)
Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases (2002) (98)
Randomised controlled trial of mesalazine in IBS (2014) (94)
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice (2017) (87)
Role of nitric oxide‐ and vasoactive intestinal polypeptide‐containing neurones in human gastric fundus strip relaxations (2000) (87)
Do we need a new gastro‐oesophageal reflux disease questionnaire? (2004) (87)
Clinical Findings and Anti-Neuronal Antibodies in Coeliac Disease with Neurological Disorders (2002) (84)
Gastrointestinal motility disturbances in patients with orthostatic hypotension. (1985) (83)
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. (1989) (81)
Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli. (1984) (80)
Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome (2012) (79)
New insights into human enteric neuropathies (2004) (78)
Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. (2004) (78)
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome (2017) (78)
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood. (2014) (77)
The pharmacological treatment of acute colonic pseudo‐obstruction (2001) (75)
Primary enteric neuropathies underlying gastrointestinal motor dysfunction. (2000) (74)
5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. (2005) (73)
Anti-ganglioside antibodies in coeliac disease with neurological disorders. (2006) (70)
A Mutation in Telethonin Alters Nav1.5 Function* (2008) (69)
Enteric neuropathy evoked by repeated cisplatin in the rat (2011) (68)
Apoptotic cell death of human interstitial cells of Cajal (2009) (68)
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial (2018) (68)
Detection of substance P immunoreactivity in human peripheral leukocytes (1998) (68)
Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia (1999) (68)
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier (2021) (68)
Effect of prucalopride on symptoms of chronic constipation (2013) (67)
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction (2008) (65)
Gastro-oesophageal reflux and interstitial lung disease. (2006) (64)
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons (2012) (63)
Upper gastrointestinal motor activity in patients with slow-transit constipation (1996) (62)
Features and Progression of Potential Celiac Disease in Adults. (2016) (62)
Intestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected rat (2001) (62)
Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction. (2015) (59)
Review article: linaclotide for the management of irritable bowel syndrome with constipation (2014) (59)
Intestinal Transplantation for Chronic Intestinal Pseudo‐Obstruction in Adult Patients (2004) (58)
Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation (2014) (58)
Evaluation of GERD Symptoms during Therapy. Part I (2004) (58)
Inflammatory bowel disease and irritable bowel syndrome: similarities and differences (2014) (56)
Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome (2002) (56)
Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries (2019) (54)
Neuroimmune Interaction and Anorectal Motility in Children With Food Allergy-Related Chronic Constipation (2009) (54)
Tachykinin-dependent and -independent components of peristalsis in the guinea pig isolated distal colon. (2001) (54)
Definition and investigation of dyspepsia (1989) (52)
Patient‐reported outcomes and gut dysmotility in functional gastrointestinal disorders (2011) (52)
IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients (1996) (52)
12 Pseudo-obstruction syndromes (1988) (51)
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. (2000) (50)
Review article: the pharmacological treatment of acute colonic pseudo-obstruction. (2001) (50)
Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders. (2004) (49)
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest. (2007) (49)
Current management strategies and emerging treatments for functional dyspepsia (2013) (49)
International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease (2004) (48)
The Construction of a New Evaluative GERD Questionnaire – Methods and State of the Art (2007) (48)
Postinfectious Irritable Bowel Syndrome (2009) (48)
Neurology and neuropathology of the pancreatic innervation. (2002) (47)
Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. (1998) (47)
Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility. (1986) (47)
GERD 2003 – A Consensus on the Way Ahead (2003) (47)
Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients (2012) (47)
Diagnosis and therapy of irritable bowel syndrome (2004) (46)
Audit of digestive complaints and psychopathological traits in patients with eating disorders: a prospective study. (2013) (45)
Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy (2014) (44)
Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. (2010) (43)
Fecal Clostridiales distribution and short‐chain fatty acids reflect bowel habits in irritable bowel syndrome (2018) (43)
Dyspeptic symptoms in primary care. An observational study in general practice (2002) (41)
Biomarkers in IBS: when will they replace symptoms for diagnosis and management? (2009) (41)
Genetics of human enteric neuropathies (2012) (40)
Unsuccessful octreotide treatment of the watermelon stomach. (1998) (40)
Does colorectal endometriosis alter intestinal functions? A prospective manometric and questionnaire-based study. (2012) (40)
Evaluation of GERD Symptoms during Therapy. Part II (2004) (40)
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity (2020) (40)
Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. (1999) (39)
Evaluation of GERD Symptoms during Therapy (2007) (38)
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism. (2016) (38)
Gastric manometric abnormalities in patients with dyspeptic symptoms after fundoplication. (1983) (38)
HLA and enteric antineuronal antibodies in patients with achalasia (2006) (37)
Recent advances in understanding non-celiac gluten sensitivity (2018) (37)
Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV (2018) (37)
Ambulatory Intestinal Manometry (A Consensus Report on Its Clinical Role) (1997) (36)
Functional gastroduodenal disorders. (2006) (36)
Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. (2007) (35)
Review article: impact of night‐time reflux on lifestyle − unrecognized issues in reflux disease (2004) (35)
Digestive and Liver Disease (2011) (35)
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy (2010) (34)
Isolated intestinal transplant for chronic intestinal pseudo-obstruction in adults: long-term outcome. (2013) (34)
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. (1997) (34)
Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction (2016) (32)
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. (2004) (31)
Gastric Emptying and Dyspeptic Symptoms in Patients with Nonautoimmune Fundic Atrophic Gastritis (2000) (30)
Herpes simplex virus type 1 infection of the rat enteric nervous system evokes small-bowel neuromuscular abnormalities. (2010) (30)
Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms. (2003) (30)
Prucalopride exerts neuroprotection in human enteric neurons. (2016) (30)
Implications of SARS‐CoV‐2 infection for neurogastroenterology (2021) (30)
Acute abdominal pain in the emergency department of a university hospital in Italy (2016) (29)
Is gastroparesis a gastric disease? (2019) (29)
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23–q24 (2007) (29)
Pain versus discomfort—is differentiation clinically useful? (2001) (29)
Review article: From gastrin to gastro‐oesophageal reflux disease – a century of acid suppression (2006) (28)
Postinfectious gastroparesis related to autonomic failure: a case report (2006) (28)
Comparison between small bowel manometric patterns and full‐thickness biopsy histopathology in severe intestinal dysmotility (2018) (28)
Chronic intestinal pseudo-obstruction related to viral infections. (2010) (28)
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. (1995) (28)
Clinical approach to diarrhea (2012) (27)
Probiotics and Irritable Bowel Syndrome: Rationale and Clinical Evidence for Their Use (2008) (27)
Determination of ReQuestTM-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies (2005) (27)
Contrast-Enhanced Ultrasound in the Differential Diagnosis of Exocrine Versus Neuroendocrine Pancreatic Tumors (2013) (27)
Clinical use of manometry for the diagnosis of intestinal motor abnormalities. (2000) (25)
Unsolved problems in the management of patients with gastro-oesophageal reflux disease. (2003) (25)
RETRACTED ARTICLE: Gut microbiota and related diseases: clinical features (2010) (25)
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study (2021) (24)
Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome (2010) (24)
Clinical trial design in adult reflux disease: a methodological workshop (2008) (24)
Serological tests to monitor treatment of Helicobacter pylori (1992) (24)
Helicobacter pylori Infection and Gastric Function in Patients with Fundic Atrophic Gastritis (2001) (23)
Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review with Meta-Analysis (2021) (23)
Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse (2003) (23)
Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon? (2010) (23)
Sympathetic hyperactivity in patients with ulcerative colitis (2007) (23)
Review Article: pain versus discomfort--is differentiation clinically useful? (2001) (22)
Non-Celiac Gluten Sensitivity in the Context of Functional Gastrointestinal Disorders (2020) (22)
HOX11L1: a promoter study to evaluate possible expression defects in intestinal motility disorders. (2002) (22)
Determination of ReQuest™-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies (2005) (21)
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea. (2017) (21)
Expression and regulation of α-transducin in the pig gastrointestinal tract (2013) (20)
Slow gallbladder emptying reverts to normal but small intestinal transit of a physiological meal remains slow in celiac patients during gluten‐free diet (2012) (20)
Management of dyspeptic patients by general practitioners and specialists (1998) (19)
Impaired intestinal barrier integrity in the colon of irritable bowel syndrome patients : involvement of soluble mediators (2008) (19)
Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus. (2005) (19)
Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction. (1992) (19)
Involvement of endogenous tachykinins and CGRP in the motor responses produced by capsaicin in the guinea-pig common bile duct (1999) (19)
µ‐opioid receptor, β‐endorphin, and cannabinoid receptor‐2 are increased in the colonic mucosa of irritable bowel syndrome patients (2019) (18)
Standards for non-invasive methods for gastrointestinal motility: scintigraphy. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente (GISMAD). (2000) (18)
A 5-Year Experience of Benign Pancreatic Hyperenzymemia (2014) (18)
Upper gastrointestinal bleeding due to duodenal metastasis from primary lung carcinoma. (2002) (18)
Neurogenic chronic intestinal pseudo-obstruction: antineuronal antibody-mediated activation of autophagy via Fas. (2008) (18)
One-day therapy for treatment ofHelicobacter pylori infection (1993) (18)
Risk indicators of organic diseases in uninvestigated dyspepsia: a one-week survey in 246 Italian endoscopy units. (1999) (18)
Rifaximin and Helicobacter pylori eradication. (1997) (17)
Mast cell‐nerve interactions correlate with bloating and abdominal pain severity in patients with non‐celiac gluten / wheat sensitivity (2020) (17)
Comparative effects of oral cisapride and metoclopramide on gastric emptying of solids and symptoms in patients with functional dyspepsia and gastroparesis (1987) (17)
Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. (2002) (17)
Clinical features of constipation in general practice in Italy (2014) (17)
Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man. (1984) (17)
Delayed gastric emptying in functional dyspepsia (2004) (17)
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators (2018) (16)
Helicobacter pylori, mucosal inflammation and symptom perception – new insights into an old hypothesis (2001) (16)
Almost All Irritable Bowel Syndromes Are Post-Infectious and Respond to Probiotics: Controversial Issues (2007) (16)
Allergic Proctocolitis Is a Risk Factor for Functional Gastrointestinal Disorders in Children (2018) (16)
Transcriptional regulation of TLX2 and impaired intestinal innervation: possible role of the PHOX2A and PHOX2B genes (2007) (15)
Disease-related intestinal transplant in adults: results from a single center. (2014) (15)
Analysis of candidate genes for intrinsic neuropathy in a family with chronic idiopathic intestinal pseudo‐obstruction (2001) (15)
Pain and Frailty in Hospitalized Older Adults (2020) (15)
Evaluation of Helicobacter pylori sensitivity to amoxycillin and metronidazole in dyspeptic patients. (1993) (15)
European Society for Neurogastroenterology and Motility recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID‐19 pandemic (2020) (15)
Diagnostic challenges of symptomatic uncomplicated diverticular disease. (2017) (15)
Treatment of Diverticular Disease With Aminosalicylates: The Evidence (2016) (15)
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. (1994) (14)
Presence of Helicobacter pylori in gastric juice. (1991) (14)
Use of macrogol 4000 in chronic constipation. (2011) (14)
The continuing dilemma of dyspepsia (2000) (14)
Enteric neuropathology of congenital intestinal obstruction: A case report. (2006) (14)
New Developments in the Treatment of Functional Dyspepsia (2012) (13)
ReQuest-- the challenge of quantifying both esophageal and extra-esophageal manifestations of GERD. (2004) (13)
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility (2017) (13)
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease (2007) (13)
Prokinetics in the treatment of acute intestinal pseudo-obstruction. (2004) (12)
Enteric neuron density correlates with clinical features of severe gut dysmotility. (2019) (12)
Constipation: a common problem in patients with neurological abnormalities. (1998) (12)
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis (2008) (11)
Gastric acid secretion and gastric emptying of liquids in 99 male duodenal ulcer patients (1989) (11)
Gastric secretion and emptying of liquids in reflux esophagitis (1981) (11)
The effect of domperidone on the gastric emptying of solid and liquid phases of a mixed meal in patients with dyspepsia (1983) (11)
Week-end therapy for H. pylori (HP) eradication (1995) (11)
Reduced Bcl-2 expression in the enteric nervous system (ENS) as a marker for neural degeneration in patients with gastrointestinal motor disorders (GIMD) (2000) (11)
Unfulfilled wishes by gastric electrical stimulation. (2011) (11)
ReQuest: new dimensions in the assessment and management of GERD. (2005) (10)
Overlap Between GERD and IBS: Irrefutable But Subtle (2007) (10)
Dyspepsia and dyspepsia subgroups. Not all roads lead to Rome. (2002) (10)
247 Zonulin Serum Levels Are Increased in Non-Celiac Gluten Sensitivity and Irritable Bowel Syndrome With Diarrhea (2015) (10)
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? (1999) (9)
Review article: adherence to Rome criteria in therapeutic trials in functional dyspepsia (2014) (9)
What is the effect of inflammation on intestinal function? (2008) (9)
Efficacy and Safety Study of Acotiamide (Z-338) in European Patients With Functional Dyspepsia (2011) (9)
Nerve fiber overgrowth in patients with symptomatic diverticular disease (2019) (9)
Apolipoprotein B is a new target of the GDNF/RET and ET‐3/EDNRB signalling pathways (2012) (8)
Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review (2019) (8)
Benign Pancreatic Hyperenzymemia: Lights on a Clinical Challenge. (2017) (8)
Effects of Dietary Fat on Postprandial Gastrointestinal Motility Are Inhibited by a Cholecystokinin Type A Receptor Antagonist (1994) (8)
Reproducibility of a solid and of a liquid caloric meal for gastric emptying studies. (1998) (8)
An expert consensus definition of failure of a treatment to provide adequate relief (F‐PAR) for chronic constipation – an international Delphi survey (2017) (8)
Nickel sensitization in patients with gastro-esophageal reflux disease (2016) (7)
The effect of different dosage schedules of cisapride on gastric emptying in idiopathic gastroparesis (2004) (7)
T1394 Mesalazine Treatment for Intestinal Immune Activation in Patient with Irritable Bowel Syndrome: A Randomized Controlled Pilot Trial (2008) (7)
713 Randomized Placebo Controlled Mulicenter Trial of Mesalazine in Patients With Irritable Bowel Syndrome (IBS) (2014) (7)
Best cut‐off values for [14C]‐urea breath tests for Helicobacter pylori detection (2003) (7)
Sigmoid compliance and visceral perception in spinal cord injury patients (2012) (7)
Relevance of gastrointestinal motor disturbances in functional dyspepsia. (1998) (6)
Effects of short- and long-term administrations of famotidine and ranitidine on some pituitary, sexual and thyroid hormones. (1987) (6)
Editorial: Reflux, Dyspepsia, and Rome III (or Rome IV?) (2010) (6)
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation (2022) (6)
Validation of radioisotopic labelling techniques in gastric emptying studies. (1987) (6)
Management of dyspepsia in primary care. Dyspepsia subgroups are useful in determining treatment. (1998) (6)
The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer. (1986) (6)
The Rome II Criteria for patients with functional gastroduodenal disorders. (2003) (6)
Small bowel manometry [1] (multiple letters) (1997) (6)
A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy. (2008) (6)
INPP4B overexpression and c‐KIT downregulation in human achalasia (2018) (6)
Update on Helicobacter pylori research. Dyspepsia. (1997) (5)
How should Helicobacter pylorinegative patients be managed? (1999) (5)
Symptoms and gastric functions in dyspepsia – goodbye to gastroparesis or to inadequate studies? (1997) (5)
843 Mucosal Immune Biomarkers in Patients With Irritable Bowel Syndrome (2013) (5)
Methodology of Gastroduodenal Manometry (1990) (5)
Ultrasonographic evaluation of gastric antral distension induced by a water load test, in healthy subjects and patients with functional dyspepsia (2001) (5)
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids. (2019) (5)
475j Nerve Growth and Plasticity in the Colonic Mucosa of Patients With Irritable Bowel Syndrome (2010) (5)
Impaired contractility of colonic muscle cells in a patient with chronic intestinal pseudo-obstruction. (2008) (5)
Mast cells in chronic inflammation, pelvic pain and depression in women (2017) (5)
zonulin serum levels are increased in non-celiac gluten sensitivity and irritable bowel syndrome (2015) (5)
Multimodal Surgical Approach for Adult Patients With Chronic Intestinal Pseudo-Obstruction: Clinical and Psychosocial Long-term Outcomes. (2018) (5)
Neuroimmune interactions in the colonic mucosa of irritable bowel syndrome patients (2000) (5)
Mode of administration of the patient assessment of upper gastrointestinal disorders-symptom severity (PAGI-SYM) and patient assessment of upper gastrointestinal disorders-quality of life (PAGI-QOL) (2001) (5)
[Post-infectious irritable bowel syndrome]. (2011) (5)
Isolated metastasis to the gallbladder of a malignant melanoma of the skin. Report of a case. (1989) (4)
Neuroendocrine regulation of gastrointestinal motility. Normal and abnormal physiology. (1993) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Management of dyspepsia in general practice. A critical assessment. (1998) (4)
Effects of chronic oral administration of clebopride and metoclopramide on gastric emptying of solids in patients with functional dyspepsia (1985) (4)
Best response distribution of 12-week treatment with prucalopride (RESOLOR) in patients with chronic constipation: combined results of three randomised, double-blind, placebo-controlled phase iii trials (2011) (4)
PROXIMAL G-E REFLUX INPATIENTES WITH UNEXPLAINED OTOLARYNGOLOGIC (ORL) SYMPTOM. AMULTICENTER STUDY IN ITALY. (1997) (4)
Reduced Bcl-2 expression and increased myenteric neuron apoptosis in patients with idiopathic enteric neuropathy (IEN) (2005) (4)
Request: Development and psychometric validation of a new evaluative symptom-scale in gastroesophageal reflux disease (GERD) (2003) (4)
P.01.14 CURRENT PRACTICE OF GASTROENTEROLOGISTS IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION IN ITALY: DATA FROM THE ITALIAN REGISTRY ON H. PYLORI TREATMENT (2019) (4)
Chemokine expression and lymphocyte subsets in patients with idiopathic myenteric ganglionitis (IMG) (2000) (4)
Evaluation of GERD Symptoms during Therapy (2007) (4)
A european survey of constipation and related behaviour in the general population (2000) (4)
Inhibition by pirenzepine of nocturnal gastric acid secretion in duodenal ulcer patients. (1981) (4)
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
Perspectives on irritable bowel syndrome: where have we been? Where are we now? (2013) (4)
Autoimmune Hepatitis and Celiac Disease: Case Report Showing an Entero-Hepatic Link (2010) (4)
Fiber and macrogol in the therapy of chronic constipation. (2013) (4)
Effect of the removal of coffee waxes on gastric acid secretion and serum gastrin levels in healthy volunteers (1989) (4)
[Effect of alkaline-earth water on gastric emptying time in patients with anorganic dyspepsia]. (1987) (4)
[Comparison of methods: gastro-duodenal manometry and study of gastric emptying]. (1991) (3)
How should Helicobacter pylori negative patients be managed? (1999) (3)
714 Randomized Placebo-Controlled Multicenter Study on the Effect of Palmitoyl-Ethanolamide and Polydatin on Immune Activation in Patients With Irritable Bowel Syndrome (2014) (3)
International comparative study of the prevalence and impact of gastrointestinal symptoms: an introduction. (1999) (3)
Role of inflammation in pediatric irritable bowel syndrome (2022) (3)
Widespread Eradication of Helicobacter pylori: A Debate (1997) (3)
COMPARISON OF THE ANTISECRETORY EFFECTS OF OMEPRAZOLE AND FAMOTIDINE ON PEPTONE-MEAL-STIMULATED GASTRIC ACID SECRETION IN PATIENTS WITH DUODENAL ULCER (1991) (3)
Effects of acute cold pressor test on vagally stimulated gastric acid secretion and circulating levels of human pancreatic polypeptide and gastrin. (1994) (3)
Asymptomatic peptic ulcer disease. Is it worth looking for? (1991) (3)
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. (2019) (3)
Su1659 - A Randomized, Controlled, Single-Blind, Cross-Over Study Assessing the Effect of Green Kiwifruit on Digestive Functions and Microbiota in Constipated Patients (2018) (3)
Post COVID-19 irritable bowel syndrome (2022) (3)
Expression and role of 5-HT7 receptors in modulating peristalsis and accommodation in the guinea pig ileum (2006) (3)
A Possible Role of Food Intolerance in the Pathogenesis of Gastroesophageal Reflux Disease (2009) (3)
unctional Gastroduodenal Disorders (2006) (3)
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier (2021) (3)
Managing the dyspeptic patient–an interactive discussion (2001) (3)
Gut epithelial and vascular barrier abnormalities in patients with chronic intestinal pseudo‐obstruction (2019) (3)
Idiopathic dyspepsia (2005) (2)
Alimentary tract andpancreas Chronic idiopathic intestinal pseudo-obstructi on: clinical andintestinal manometric findings (1987) (2)
Effect ofchronic administration ofcisapride ongastric emptying ofasolid mealandondyspeptic symptomsin patients withidiopathic gastroparesis (1987) (2)
Detection of anticonductive tissue autoantibodies in a patient with chronic intestinal pseudo-obstruction and sick sinus syndrome (2013) (2)
The evolution of anti-ulcer therapy with cimetidine. Is a single large nocturnal dose of cimetidine the right therapy for duodenal ulcer? (1986) (2)
Feedback regulation and sensation (1994) (2)
[The innervation of the digestive tract: its morphofunctional and neurochemical aspects]. (1996) (2)
Does dietary iodine prevent gastric cancer? (1998) (2)
Cisapride in Gastroesophageal Reflux Disease: Effect on Gastric Emptying and Clinical Results (1992) (2)
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer. (1984) (2)
Atypical presentation of acute idiopathic megacolon in a 14-year-old patient (2012) (2)
Tinnitus in patients on therapy with proton pump inhibitors (PPI) and in PPI non-users (2014) (2)
Small bowel motor abnormalities in malnourished symptomatic adults complaining of severe digestive symptoms with and without functional subocclusive episodes (2000) (2)
Gastric emptying, electrical and contractile activity (1992) (2)
Feedback regulation and sensation. Frontiers in gastric emptying. (1994) (2)
W1370 Mucosal Immune Activation in Irritable Bowel Syndrome Is Gender-Dependent and Associated with Digestive Symptoms (2008) (2)
Intestinal neuro-immune interactions in irritable bowel syndrome are gender dependent (2001) (2)
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) (2021) (2)
Mo2035 Acute Salmonella Gastroenteritis Occurring Early in Life but Not in Adulthood Is a Risk Factor for Post-Infectious Irritable Bowel Syndrome (PI-IBS) in the Long Term (2013) (2)
Evidence of enteric angiopathy and neuromuscular hypoxia in patients with mitochondrial neurogastrointestinal encephalomyopathy. (2021) (2)
Rectosigmoid compliance and visceral perception in spinal cord injury patients. (2006) (2)
Submucous rather than myenteric neurons are activated by supernatants of mucosal biopsies from IBS patients (2009) (2)
Review article: managing the dyspeptic patient--an interactive discussion. (2001) (2)
[Gastroesophageal reflux disease: therapeutic features (Part II)]. (2007) (1)
Small bowel motility and natural history of chronic intestinal pseudo-obstruction (1998) (1)
Comparison between two different posologies of ranitidine on 24-hour gastric acidity in duodenal ulcer patients. (1986) (1)
The stomach and obesity: the missing link, at last? (2017) (1)
Patients with duodenitis have gastric secretory and motor functions like those of duodenal ulcer patients: results of a short-term treatment with ranitidine. (1991) (1)
PC.02.3 POSTINFECTIOUS DYSPEPSIA AND IRRITABLE BOWEL SYNDROME 16 YEARS AFTER A SINGLE OUTBREAK OF SALMONELLA GASTROENTERITIS AND THE RELEVANCE OF EARLY-LIFE INFECTION (2013) (1)
978 Mucosal Biopsies from IBS Patients Release Mediators That Sensitize Human Enteric Nervous System (ENS) (2008) (1)
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register (2019) (1)
Excitatory effect of colonic mast cell mediators of irritable bowel syndrome patients on enteric cholinergic motor neurons (2006) (1)
Management of gastroesophageal reflux disease. (2003) (1)
IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Italian Helicobacter pylori Study Group. (1996) (1)
Retraction Note to: Gut microbiota and related diseases: clinical features (2015) (1)
Molecular and Pathological Characterization of a Non-Aganglionic Congenital Megacolon in the Rabbit (2011) (1)
Chronic Intestinal Pseudo-Obstruction: A Neuropathological Approach (2014) (1)
Chronic oral administration of lansoprazole does not affect the hypothalamic pituitary gonadal axis in healthy young men. (1995) (1)
Intravenous cimetidine and methylxanthines stimulated gastric acid secretion in man. (1979) (1)
S1300 Long-Term Efficacy of Oral Prucalopride in Patients With Chronic Constipation (2010) (1)
Diagnosing and treating dyspepsia. Current practice and new developments. (2000) (1)
Evaluation of gastrointestinal innervation in humans (1993) (1)
Su1215 Escherichia coli Nissle 1917 Reinforces Intestinal Epithelial Barrier and Prevents Permeability Alterations Induced by Cytokines and PAR-2 Activation: An In Vitro Study (2016) (1)
Excitatory actions of supernatants released from mucosal biopsies of IBS patients is mediated by proteases, serotonin and histamine (2008) (1)
Sa1567 - Gastroparesis is More an Intestinal than a Gastric Disease (2018) (1)
Pathophysiology and Clinical Management of Bile Acid Diarrhea (2022) (1)
61 Interferon-Gamma Interplay With Serotonin Metabolism and Mucosal Permeability in Irritable Bowel Syndrome (2014) (1)
The Relation Between Adverse Events on Day 1 and Pharmacodynamic Effects on Day 1 of Treatment With Prucalopride (2011) (1)
Understanding the Pathophysiology of IBS (2013) (1)
Protective effect of sulglycotide on human gastric mucosa exposed to taurocholic acid. (1987) (1)
Tu1456 MAST CELL-NERVE INTERACTIONS CORRELATE WITH BLOATING AND ABDOMINAL PAIN SEVERITY IN PATIENTS WITH NON-CELIAC GLUTEN / WHEAT SENSITIVITY (2020) (1)
A mediator cocktail released from mucosal biopsies of IBS patients excites human and guinea-pig enteric neurons (2007) (1)
Dried plums vs. psyllium (2011) (1)
Gastric Functions and Helicobacter pylori Infection in Patients with Fundic Atrophic Gastritis (1994) (1)
Management of Dyspepsia in General Practice (2012) (1)
Relationship between postrandial symptoms and gastric emptying in functional dyspepsia (1998) (1)
Diagnostic value of a validated questionnaire for dyspepsia (1998) (1)
Colonic Mucosal Mediators From Patients With Irritable Bowel Syndrome Excite Guinea Pig Enteric Cholinergic Motor Neurons via Purinergic, Prostaglandin, and TRPV1 Pathways (2011) (1)
Prevalence of irritable bowel syndrome in Italy: A population-based study (2001) (1)
Esophageal bolus contact time and chemical clearance may differentiate patients with non-erosive reflux disease: an impedance-pH monitoring study (2015) (1)
Anti-neuronal antibodies in patients with celiac disease and neurological disorders (2003) (1)
From rome 1 to rome 2 criteria for functional gastroducdenal disorders (2001) (1)
ast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons n Irritable Bowel Syndrome (2007) (0)
Inhibition of gastric acid secretion and therapeutic results: is there any correlation? (1990) (0)
11 OP Trafficking of galanin receptor 1 and 2 in HEK293 transfected cells (2002) (0)
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome. (2023) (0)
CS.1.1 ALTERED SEROTONIN SIGNALING AND EXTRINSIC SENSORY NEURON ACTIVATION IN IRRITABLE BOWEL SYNDROME (2010) (0)
OC.10.1 NEUROPLASTIC CHANGES IN THE COLONIC MUCOSA OF PATIENTS WITH IRRITABLE BOWEL SYNDROME (2010) (0)
Su1641 Audit of Gastrointestinal Symptoms and Psychopathological Traits in Patients With Eating Disorders: A Prospective Study (2012) (0)
Su1942 Mucosal Immune System and Its Interaction With Microbiota in Patients With Diverticular Disease (2016) (0)
Subject Index Vol. 69, 2004 (2004) (0)
OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME (2023) (0)
Roundtable discussion: Differences between Japan and Western countries in the treatment of dyspepsia (1998) (0)
S1667 A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa (2008) (0)
Endoscopic Sphincterotomy ( ES ) Applied for Acute Biliary Pancreatitis ( ABP ) Prevents Further Attack of this Disease . A Prospective Follow-Up Study (2006) (0)
An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy (2021) (0)
Program of the Second Meeting of the American Motility Society (2005) (0)
Su2050 Supernatants of Mucosal Biopsies From Irritable Bowel Syndrome Patients Impair Human Colonic Smooth Muscle Contractility (2015) (0)
Anatomical Laser Microdissection of the Ileum Reveals mtDNA Depletion Recovery in A Mitochondrial Neuro-Gastrointestinal Encephalomyopathy (MNGIE) Patient Receiving Liver Transplant (2022) (0)
Reply (2005) (0)
[Effect of tiropramide on solid gastric emptying time in man]. (1986) (0)
Morpho-functional evidence for tachykinins as major non-cholinergic excitatory transmitters in the guinea pig common bile duct (CBD) (1998) (0)
Response to Drs Shearer and Ford (2014) (0)
Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction (2023) (0)
9 PS Protease-activated receptor-2 (PAR-2) and mast cell tryptase in irritable bowel syndrome (2002) (0)
Is ileal brake from fat a physiological mechanism of gastric emptying control in human? The role of PYY (1991) (0)
142 Neuro-Immune Interactions in Patients With Diverticular Disease (2015) (0)
Quality of life in patients affected by severe digestive syndromes with and without sub-occlusive episodes. (2007) (0)
Mucosal Neuroplasticity and Its Correlation With Symptoms in Patients With Irritable Bowel Syndrome (2011) (0)
Sa1379 VIP Expression in the Submucosal Plexus in Patients With Parkinson Disease and Chronic Constipation (2015) (0)
CS2.4 MESALAZINE TREATMENT FOR INTESTINAL IMMUNE ACTIVATION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED CONTROLLED PILOT TRIAL (2008) (0)
Role of scintigraphic labeling techniques in the relationship between 13C-acid octanoic breath test and scintigraphy for studying gastric emptying (2001) (0)
OC.04.4 MUCOSAL IMMUNE BIOMARKERS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (2013) (0)
P.07.1 Role of Distinct 5-Ht Receptors in the Guinea Pig Distal Colon Peristalsis (2012) (0)
SeHCAT test for bile acid malabsorption: may “the old” become “the gold one” in the diagnostic burden of chronic diarrhea? (2021) (0)
OC.05.4: MUCOSAL MEDIATORS FROM PATIENTS WITH IRRITABLE BOWEL SYNDROME STIMULATE ENTERIC CHOLINERGIC MOTOR NEURONS IN VITRO VIA PURINERGIC, PROSTAGLANDIN, AND TRPV1 PATHWAYS (2011) (0)
The relationship between 13C-acid octanoic breath test and scintigraphy in the evaluation of gastric emptying is affected by scintigraphic labeling technique (2001) (0)
Su2019 Functional Characterization of a Novel RAD21 Mutation in Familial Chronic Intestinal Pseudo-Obstruction (CIPO) (2014) (0)
Su1852 The 5-HT4 Selective Agonist Prucalopride Exerts Neural and Epithelial Protective Effects In Vitro (2015) (0)
OC.14.3 IMPAIRMENT OF HUMAN COLONIC SMOOTH MUSCLE CONTRACTILITY FOLLOWING EXPOSURE TO MUCOSAL BIOPSY SUPERNATANTS FROM IRRITABLE BOWEL SYNDROME PATIENTS (2014) (0)
Mo1854 Quantification of Endogenous Agonist of Transient Receptor Potential (TRP) in Tissues From Irritable Bowel Syndrome (IBS) Patients (2012) (0)
OC.05.1: COLONIC MUCOSAL NEUROPLASTICITY AND ITS INVOLVEMENT IN SYMPTOM GENERATION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (2011) (0)
Contents Vol. 69, 2004 (2004) (0)
The shorter, the better - A review of the evidence for a shorter contraceptive hormone-free interval (2017) (0)
Tu1473 NON-CELIAC GLUTEN SENSITIVITY CAN BE DIFFERENTIATED FROM IRRITABLE BOWEL SYNDROME: A DIAGNOSTIC ALGORITHM (2020) (0)
Clinical and economic profile of prucalopride in the treatment of chronic constipation in women (2012) (0)
Review article: the continuing dilemma of dyspepsia. (2000) (0)
Treatment of dyspepsia. (1998) (0)
Reviewer Recognition 2006 (2007) (0)
P.12.5 Does Deep Infiltrating Endometriosis Alter Anorectal Motility and Digestive Symptoms (2014) (0)
NEURO-IMMUNE INTERACTIONS AND ANORECTAL MOTILITY IN CHILDREN WITH FOOD-ALLERGY RELATED CONSTIPATION (2006) (0)
Mo1855 Oral Treatment With Elafin-Recombinant Probiotics Improves Visceral Pain and Hypersensitivity in a Model of Irritable Bowel Syndrome (IBS) (2012) (0)
Mo1598 - Uncomplicated Diverticular Disease Patients Show Colonic Nerve Sprouting and Immune Activation (2018) (0)
OC.03.6 GASTROINTESTINAL AUTOIMMUNE DISEASES IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY: A COHORT STUDY (2023) (0)
Editorial Board (2002) (0)
Characteristics and gastric emptying of patients with functional gastroduodenal disorders according to the Rome II Criteria (2000) (0)
Have the National Health Care System recommendations influenced the move of Italian General Practitioners towards the management of Helicobacter pylori infection? (2000) (0)
An interdisciplinary approach to investigate the English spotting locus and its association with megacolon in the domestic rabbit: a new putative model of enteric neuronal dysfunction (2020) (0)
Small bowel manometry. (1997) (0)
Su1660 - The Fecal Microbial Ecosystem in Irritable Bowel Syndrome is Distinct According to Bowel Habit Characteristics (2018) (0)
The Effect of Bile Lipid Concentration ( BLC ) and Biliary Deoxycholic Acid ( DCA ) on the Solubilization of Biliary Cholesterol ( CH ) in Vesicles (2006) (0)
7 PS Type 1 anti-neuronal nuclear antibodies (ANNA-1) induce neuronal apoptosis through APAF-1 and CASPASE-3 activation in SH-SY5Y cells (2002) (0)
Chronic intestinal pseudo-obstruction in children and adults : diagnosis and therapeutic options Running title : Chronic intestinal pseudo-obstruction in children and adults (2017) (0)
Evaluating GERD Symptoms: ReQuest (2007) (0)
[Current status of the medical therapy of gastric and duodenal ulcer]. (1987) (0)
Molecular genetics of human enteric neuropathies. (2007) (0)
New perspectives in Irritable Bowel Syndrome: introduction to part 1. (2009) (0)
Intestinal epithelial barrier disfunction in patients with chronic intestinal pseudo-obstruction (2015) (0)
AJG-21-1347 147..157 (0)
From meetings (1988) (0)
T.02.2 GUT EPITHELIAL PERMEABILITY IS ALTERED IN IBS PATIENTS: CORRELATIONS WITH SYMPTOMS AND UNDERLYING MOLECULAR MECHANISMS (2023) (0)
Congenital intestinal obstruction mimicking chronic idiopathic intestinal pseudo-obstruction: A case report (2007) (0)
Advanced brain MR study in mitochondrial neurogastrointestinal encephalomyopathy: double dissociation between severe CIPO, mild neurological, and severe neuroradiological findings (2014) (0)
Subject Index Vol. 27, Suppl. 1, 2009 (2010) (0)
Clinical usefulness of biochemical monitoring in colorectal cancer (1996) (0)
P.01.32 PROBIOTIC SUPPLEMENTATION IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION IN ITALY: DATA FROM THE ITALIAN REGISTRY ON H. PYLORI TREATMENT (2019) (0)
609 Increased Expression of μ-opioid and Cannabinoid Receptors in the Colonic Mucosa of Patients With Irritable Bowel Syndrome (IBS) (2015) (0)
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both (2023) (0)
Chapter 2: Gastroduodenal Disorders (2016) (0)
[Mastication and time of gastric emptying. Clinical research]. (1984) (0)
T01.02.5 FOOD AND NON- FOOD ALLERGIES IN DIGESTIVE AND EXTRADIGESTIVE MANIFESTATIONS OF FUNCTIONAL GASTROINTESTINAL DISORDERS (2020) (0)
Tu1251 Mitochondrial Neurogastrointestinal Encephalomyopathy: The Liver As a Tissue Source to Restore Thymidine Phosphorylase Activity (2014) (0)
Treatment of duodenal ulcer with a single nocturnal dosage of oxmetidine (1985) (0)
OC.08.5 NEUROLOGICAL ABNORMALITIES IN PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION (2010) (0)
How Relevant Is Symptom Evaluation in NERD? (2008) (0)
Abstracts of the International Conference on stress and digestive motility (1989) (0)
Endocrine effects of the H2-receptor antagonists cimetidine and ranitidine. (1983) (0)
New perspectives in irritable bowel syndrome: introduction to part 2. (2009) (0)
UvA-DARE ( Digital Academic Repository ) Functional gastroduodenal disorders (2017) (0)
Clinical and Pathological Features of Severe Gut Dysmotility. (2022) (0)
Chronic intestinal pseudo-obstruction: clinical and pathophysiological features. (2007) (0)
Gut microbiota signatures and modulation in irritable bowel syndrome (2022) (0)
Changes in calcitonin gene-related peptide (CGRP) and substance P/tachykinin (SP/TK) immunoreactivity (IR) in sensory nerves of rats chronically infected with H. pylori (HP) (1998) (0)
Gastric antral distension and symptoms evaluation induced by a water load test in healthy subjects and patients with functional dyspepsia (2001) (0)
β3-adrenoceptor stimulation ameliorates experimental colitis in rats (2003) (0)
PROXIMAL OESOPHAGEAL PHMETRY IN CONTROLS AND IN PATIENS WITH REFLUX OR OTOLARYNGOLOGIC (ORL) SYMPTOMS. A MULTICENTER STUDY IN ITALY. (1996) (0)
[Some practical questions on chronic stipsis treatment with prucalopride]. (2014) (0)
Clinical trial design in adult reflux disease: a methodological (2008) (0)
Neuroplasticity of the Enteric Nervous System Induced by Inflammatory Conditions of the Gut (2006) (0)
Serological tests to monitor treatment of Helicobacter pylori. (1992) (0)
390 Impairment of Human Colonic Smooth Muscle Contractility Following Exposure to Mucosal Biopsy Supernatants Obtained From Irritable Bowel Syndrome Patients (2014) (0)
P.02.5 THE ROLE OF NEURO-IMMUNE INTERACTIONS AND NERVE SPROUTING IN COLONIC DIVERTICULAR DISEASE (2019) (0)
Modifications to α-transducin and neuropeptide immunoreactivities evoked by feeding in the GI tract (2009) (0)
Su1722 GASTROINTESTINAL VASCULAR CHANGES IN GENETIC AND IDIOPATIC FORMS OF CRONIC INTESTINAL-PSEUDO OBSTRUCTION (2020) (0)
Key Paper Evaluation (2010) (0)
Consensus guidelines on severe acute pancreatitis (2017) (0)
T2064 Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome (2010) (0)
M2014 Evidence of Neurological Impairment in Patients With Severe Gut Dysmotility (2010) (0)
Asymptomatic Peptic Ulcer Disease (1991) (0)
OC.02.4 INTERFERON-GAMMA INTERPLAY WITH SEROTONIN METABOLISM AND MUCOSAL PERMEABILITY IN IRRITABLE BOWEL SYNDROME (2014) (0)
[Gastroesophageal reflux disease: clinical and pathophysiological features (part I)]. (2007) (0)
Novel Mutations in Neurogenic Chronic Intestinal Pseudo-Obstruction Identified by High-Throughput Sequencing (2017) (0)
Patients with functional gastroduodenal disorders classified by predominant symptoms according to the Rome II criteria, have different characteristics and gastric emptying (2000) (0)
OC3.07.4 MUCOSAL IMMUNE ACTIVATION IN IRRITABLE BOWEL SYNDROME IS GENDER-DEPENDENT AND ASSOCIATED WITH DIGESTIVE SYMPTOMS (2008) (0)
The Construction of a New Evaluative GERD Questionnaire – Methods and State of the Art (2004) (0)
1000 Seronegative Celiac Disease: Prevalence and Clinical Features in a Tertiary Referral Center (2016) (0)
NGM 2010 HOST ANMS (2010) (0)
Poster Sessions (2015) (0)
[New etiopathogenic, clinical and therapeutic findings in multiple endocrine neoplasia type 1]. (1996) (0)
Overlapping functional syndromes: a way forward for medical therapy? (2008) (0)
Su1620 – Nerve Fiber Sprouting and Neuro-Immune Interactions in Patients with Symptomatic Uncomplicated Diverticular Disease (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Vincenzo Stanghellini?

Vincenzo Stanghellini is affiliated with the following schools: